FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088254897> ?p ?o ?g. }

• W3088254897 endingPage "108" @default.
• W3088254897 startingPage "99" @default.
• W3088254897 abstract "Antibody-mediated transfusion-related acute lung injury (TRALI) is caused by antibodies against human leukocyte antigens (HLAs) or human neutrophil antigens (HNAs), and is one of the most serious complications associated with transfusion medicine. Prevention strategies like testing allo-exposed female blood donors have not yet been introduced nationwide in Austria. To assess the need and feasibility of routine leukocyte antibody testing, the prevalence of leukocyte-reactive antibodies in an Austrian female donor population was been determined using classical cell-based methods which were compared with a high-throughput bead-based method.Sera from 1,022 female blood donors were screened using a granulocyte aggregation test (GAT) and a white blood cell immunofluorescence test (WIFT) after retesting and specification of positive samples by granulocyte immunofluorescence test (GIFT) and monoclonal antibody-specific immobilization of granulocyte antigens (MAIGA). Potential HLA reactivities were confirmed using the microbeads assay LabScreenTM Mixed. The results in 142 donor sera and 38 well-defined reference sera were investigated by the microbeads assay LabScreenTM Multi and compared with classical cell-based methods.Reactivity with either granulocytes and/or lymphocytes was detected in 79 sera (7.7%), with the majority being HLA-specific. Antibodies against HNA were obtained in 7 samples (0.7%). The aggregating potential of the detected antibodies was observed in 9 cases (0.9%). Most of the leukocyte-reactive antibodies occurred at a donor age of between 35 and 59 years (n = 61). LabScreen Multi showed good agreement (κ = 0.767) for HNA antibody detection by cell-based assays, but double/multiple specificities (100% of 7 anti-HNA-1b sera) as well as false-negative results (40% of 15 HNA-3-specific sera) occurred.Leukocyte-reactive antibody screening is advised in Austrian female donors for safe blood transfusion, including single-donor convalescent plasma treatment of COVID-19 that may be implemented soon. For the introduction of LabScreen Multi, the combination with GAT should be considered to ensure correct anti-HNA-3a detection." @default.
• W3088254897 created "2020-10-01" @default.
• W3088254897 creator A5018100827 @default.
• W3088254897 creator A5018141989 @default.
• W3088254897 creator A5018234410 @default.
• W3088254897 creator A5024617009 @default.
• W3088254897 creator A5025843510 @default.
• W3088254897 creator A5030288902 @default.
• W3088254897 creator A5061312063 @default.
• W3088254897 creator A5070000881 @default.
• W3088254897 creator A5073673837 @default.
• W3088254897 date "2020-09-23" @default.
• W3088254897 modified "2023-09-25" @default.
• W3088254897 title "Leukocyte-Reactive Antibodies in Female Blood Donors: The Austrian Experience" @default.
• W3088254897 cites W1707853451 @default.
• W3088254897 cites W1899357462 @default.
• W3088254897 cites W1954183036 @default.
• W3088254897 cites W1954803152 @default.
• W3088254897 cites W1964906546 @default.
• W3088254897 cites W1972903864 @default.
• W3088254897 cites W1977972902 @default.
• W3088254897 cites W1993264753 @default.
• W3088254897 cites W1998475303 @default.
• W3088254897 cites W2016365138 @default.
• W3088254897 cites W2036255398 @default.
• W3088254897 cites W2063274101 @default.
• W3088254897 cites W2074237369 @default.
• W3088254897 cites W2075750258 @default.
• W3088254897 cites W2101502513 @default.
• W3088254897 cites W2106438576 @default.
• W3088254897 cites W2125628655 @default.
• W3088254897 cites W2134406481 @default.
• W3088254897 cites W2137005476 @default.
• W3088254897 cites W2140477550 @default.
• W3088254897 cites W2143491379 @default.
• W3088254897 cites W2148822770 @default.
• W3088254897 cites W2157475765 @default.
• W3088254897 cites W2463443958 @default.
• W3088254897 cites W2546123549 @default.
• W3088254897 cites W2734493460 @default.
• W3088254897 cites W2791608704 @default.
• W3088254897 cites W2799506842 @default.
• W3088254897 cites W2886299467 @default.
• W3088254897 cites W2889894889 @default.
• W3088254897 cites W2916526154 @default.
• W3088254897 cites W2966855694 @default.
• W3088254897 cites W3001118548 @default.
• W3088254897 cites W3008954191 @default.
• W3088254897 cites W3012421327 @default.
• W3088254897 cites W3012546754 @default.
• W3088254897 cites W3016393661 @default.
• W3088254897 cites W4231935090 @default.
• W3088254897 doi "https://doi.org/10.1159/000509946" @default.
• W3088254897 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8077487" @default.
• W3088254897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33976610" @default.
• W3088254897 hasPublicationYear "2020" @default.
• W3088254897 type Work @default.
• W3088254897 sameAs 3088254897 @default.
• W3088254897 citedByCount "2" @default.
• W3088254897 countsByYear W30882548972023 @default.
• W3088254897 crossrefType "journal-article" @default.
• W3088254897 hasAuthorship W3088254897A5018100827 @default.
• W3088254897 hasAuthorship W3088254897A5018141989 @default.
• W3088254897 hasAuthorship W3088254897A5018234410 @default.
• W3088254897 hasAuthorship W3088254897A5024617009 @default.
• W3088254897 hasAuthorship W3088254897A5025843510 @default.
• W3088254897 hasAuthorship W3088254897A5030288902 @default.
• W3088254897 hasAuthorship W3088254897A5061312063 @default.
• W3088254897 hasAuthorship W3088254897A5070000881 @default.
• W3088254897 hasAuthorship W3088254897A5073673837 @default.
• W3088254897 hasBestOaLocation W30882548971 @default.
• W3088254897 hasConcept C147483822 @default.
• W3088254897 hasConcept C159654299 @default.
• W3088254897 hasConcept C188280979 @default.
• W3088254897 hasConcept C203014093 @default.
• W3088254897 hasConcept C2777983669 @default.
• W3088254897 hasConcept C2778236600 @default.
• W3088254897 hasConcept C2780014101 @default.
• W3088254897 hasConcept C2908647359 @default.
• W3088254897 hasConcept C542903549 @default.
• W3088254897 hasConcept C64518967 @default.
• W3088254897 hasConcept C71924100 @default.
• W3088254897 hasConcept C99454951 @default.
• W3088254897 hasConceptScore W3088254897C147483822 @default.
• W3088254897 hasConceptScore W3088254897C159654299 @default.
• W3088254897 hasConceptScore W3088254897C188280979 @default.
• W3088254897 hasConceptScore W3088254897C203014093 @default.
• W3088254897 hasConceptScore W3088254897C2777983669 @default.
• W3088254897 hasConceptScore W3088254897C2778236600 @default.
• W3088254897 hasConceptScore W3088254897C2780014101 @default.
• W3088254897 hasConceptScore W3088254897C2908647359 @default.
• W3088254897 hasConceptScore W3088254897C542903549 @default.
• W3088254897 hasConceptScore W3088254897C64518967 @default.
• W3088254897 hasConceptScore W3088254897C71924100 @default.
• W3088254897 hasConceptScore W3088254897C99454951 @default.
• W3088254897 hasIssue "2" @default.
• W3088254897 hasLocation W30882548971 @default.
• W3088254897 hasLocation W30882548972 @default.

• next